Track the KALA BIO, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €44.8m. The latest transaction was reported on 26 June 2025 (Cession). Among the most active insiders: Iwicki Mark T. The full history is openly available.
46
Insider Decl.
n/a
Thresholds
€2m
2 ops.
Buy Volume
€442,263
21 ops.
Sell Volume
46Σ signal
Buys €2m€442,263 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
15,168 shares@ US$4.7561.9% of flowCommon StockSEC:0001415889-24-018374:0
25 of 46 declarations
About KALA BIO, Inc.
KALA BIO, Inc. is a biopharmaceutical company focused on developing innovative treatments for eye diseases. It is listed on NASDAQ under the ticker KALA.